Free Trial

Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Down - Time to Sell?

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scient's shares opened at $71.75, down from the previous close of $73.77, indicating a potential selling opportunity for investors.
  • Analysts have a consensus rating of "Hold", with Citigroup restating a neutral rating and one analyst recommending a Strong Buy.
  • The company's financial ratios indicate stability, with a current ratio of 1.26 and a debt-to-equity ratio of 0.77.
  • MarketBeat previews top five stocks to own in November.

Eurofins Scient (OTCMKTS:ERFSF - Get Free Report)'s stock price gapped down prior to trading on Monday . The stock had previously closed at $73.77, but opened at $71.75. Eurofins Scient shares last traded at $71.75, with a volume of 90 shares changing hands.

Wall Street Analyst Weigh In

Separately, Citigroup restated a "neutral" rating on shares of Eurofins Scient in a research note on Friday, July 25th. One research analyst has rated the stock with a Strong Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold".

Read Our Latest Report on Eurofins Scient

Eurofins Scient Price Performance

The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77. The business's 50-day simple moving average is $76.14 and its two-hundred day simple moving average is $68.45.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.